CRWV insider notice: 52,787 RSU shares to be sold on NASDAQ
Rhea-AI Filing Summary
CoreWeave, Inc. (CRWV) reported a Form 144 notice for a proposed sale of 52,787 common shares with an aggregate market value of $7,115,159.73, planned for 10/06/2025 through Morgan Stanley Smith Barney LLC on NASDAQ. The shares were recorded as Restricted Stock Units acquired from the issuer on 09/30/2025 and are shown as issued to be sold for the account noted on the form.
The filing also discloses multiple prior sales over the past three months under 10b5-1 plans and an individual sale: several 281,250-share 10b5-1 transactions and other trust sales between 08/20/2025 and 10/01/2025, plus a 65,593-share sale by Brian Venturo on 09/30/2025. The filer affirms no undisclosed material adverse information as required by the form.
Positive
- Planned sale amount is precisely disclosed: 52,787 shares valued at $7,115,159.73
- Acquisition source is clear: shares originated as Restricted Stock Units dated 09/30/2025
- Prior sales are labelled as 10b5-1 plans, indicating prearranged trade authorizations
Negative
- Multiple large share dispositions in the prior three months (e.g., repeated 281,250-share 10b5-1 sales) increase near-term share supply
- No beneficiary or controlling-party context is provided for the selling entities, limiting insight into ultimate ownership changes
Insights
TL;DR: A recent RSU sale and multiple 10b5-1 disposals show scheduled insider-related liquidity events.
The notice records 52,787 shares from RSUs acquired on 09/30/2025 with an aggregate market value of $7,115,159.73, to be sold on 10/06/2025 through Morgan Stanley Smith Barney LLC on NASDAQ. This is a routine disclosure when insiders or related parties convert equity awards and plan sales.
Several large 10b5-1 sales and one individual sale totaling multiple hundreds of thousands of shares between 08/20/2025 and 10/01/2025 are listed, indicating ongoing prearranged sales rather than opportunistic market trades. Monitor near-term share supply impact around the listed sale dates.
TL;DR: Filings show use of Rule 10b5-1 plans and a standard Form 144 attestation.
The schedule includes multiple entries explicitly labeled as 10b5-1 Sales for entities such as WEST CLAY CAPITAL LLC and trust vehicles, which implies written trading plans or pre-authorized instructions. The filer also signs the representation required by the form that no undisclosed material adverse information is known.
Because the transactions reference prearranged plan sales, the primary compliance item is timing and plan documentation; interested parties may look for further public disclosures coinciding with these sales on or after the stated dates.